By BOPA Committee on behalf of UK SACT board on 23rd May 2025

UK SACT Board publication: Guidance on the contents of a SACT protocol

  Dear Colleague,   Please find a link to the updated publication, “Guidance for the Content of SACT Protocol,” available here: https://www.uksactboard.org/publications.   This document has been developed to support…

Read article
By BOPA on 27th April 2025

Further monographs for use of immunosuppressants in Immune-related adverse events (irAEs)

Earlier this year the BOPA Immunotherapy Group wrote, and published, four monographs to help health care professionals care for patients with immune-related adverse events. As a group we are pleased…

Read article
By BOPA on 20th January 2025

Monographs for use of immunosuppressants in Immune-related adverse events (irAEs)

Over the past year the Immunotherapy Specialist Interest Group has been working on producing high quality information to support the use of subsequent line immunosupressants for patients with irAEs in…

Read article
By BOPA Research Committee on 9th September 2024

BOPA member publication on the impact of inter-cycle treatment delays on mortality in early-stage breast cancer

We would like to share a recent BOPA member publication Pinkie Chambers et al. The impact of inter-cycle treatment delays on 5-year all-cause mortality in early-stage breast cancer: A retrospective…

Read article
By BOPA EDI subcommittee on 2nd August 2024

BOPA EDI published article now available

We are delighted to share a BOPA EDI publication is now available on line. Equity, diversity, and inclusion in oncology pharmacy practice: Everyone’s business – Pascale Dettwiller, Suhani Ghiya, Jurga…

Read article
By BOPA Committee on 12th July 2024

TRANScribing: Clinical considerations for safe and inclusive prescribing for transgender and non-binary patients

BOPA is delighted to announce the publication of TRANScribing: Clinical considerations for safe and inclusive prescribing for transgender and non-binary patients in collaboration with OUTpatients. It is estimated that one…

Read article
By BOPA GAP on 5th April 2024

Published: BOPA Delphi consensus guidelines – Co-infusion of trometamol-containing calcium folinate (Leucovorin) with systemic anti-cancer treatments

The BOPA Guidelines, Advocacy And Publications Committee is pleased to announce that the British Oncology Pharmacy Association Delphi consensus guidelines is now published on the Journal of Oncology Pharmacy Practice.…

Read article
By BOPA GAP on 20th March 2024

Published: BOPA Guide to Producing a Position Statement

As an organisation BOPA represents the interests of its members and the wider oncology pharmacy workforce by developing and adopting position statements in response to changes in healthcare policy, or…

Read article
By BOPA Committee on 9th January 2024

Prescriber competencies for reviewing and prescribing SACT

The UK SACT Board is please to announce that the new guidance on Prescriber competencies for reviewing and prescribing SACT has been published. It is available from the Publications section on the…

Read article
By BOPA on 21st September 2023

The guidance on the use of oral SACT for patients unable to swallow has been released!

Administration of oral systemic anticancer therapy (SACT) via enteral feeding tubes and other methods (Version 2) This document replaces one in the Oral SACT Counselling Handbook for Pharmacy and Nursing…

Read article
By BOPA on 21st September 2023

General principles to support SACT aseptic capacity pressures

We are delighted to confirm that the UK SACT Board has now published General principles to support Systemic Anti-Cancer Therapy aseptic capacity pressures. It is available on the UKSB website.…

Read article
By BOPA on 20th September 2023

BOPA Education & Training Standards for Registered Pharmacy Professionals working in Cancer Services

BOPA are pleased to announce that the BOPA Education & Training Standards for Registered Pharmacy Professionals working in Cancer Services have been updated to incorporate the digital passport and level…

Read article